🏠 Home  /  Services  /  Regulatory Support β€” Europe
πŸ‡ͺπŸ‡Ί European Market

Regulatory Support for
Medicinal Products in Europe

The regulatory system for medicinal products in Europe is one of the most complex globally. With varying national requirements and procedures, it presents both challenges and opportunities β€” especially for manufacturers aiming to enter the European market.

πŸ’Š Marketing Authorization Pathways

πŸ›οΈ
Centralized Procedure
EMA β€” Authorization Across All EU Member States

🌐
Decentralized Procedure
Simultaneous Multi-Country Authorization

πŸ”
Mutual Recognition Procedure
MRP β€” Based on Existing National Authorization

πŸ—ΊοΈ
National Procedure
Single Member State Authorization

🧭

Our Comprehensive Support Approach

Our expert-led regulatory support helps pharmaceutical companies seamlessly navigate every step of the compliance journey.

βœ… Dossier Preparation
βœ… EMA
βœ… Post-Approval
βœ… Lifecycle Management

πŸ”‘ End-to-End Regulatory Guidance: Fully compliant documentation aligned with EMA or national agency standards, covering all marketing authorization pathways and post-approval compliance.

Overview

End-to-End Regulatory Guidance

Dossier Preparation & Submission β€” Fully compliant documentation aligned with EMA or national agency standards.

Marketing Authorization Pathways β€” Expertise across Centralized, Decentralized, MRP, and National Procedures.

Post-Approval Compliance β€” Lifecycle management, updates, labeling, and regulatory changes.

πŸ“ž Speak with a Regulatory Expert

Why Choose the Centralized Procedure?

Pan-European Access via the Centralized Procedure

For companies aiming for pan-European access, the Centralized Procedure β€” coordinated by the European Medicines Agency (EMA) β€” offers a streamlined route. One application leads to authorization in all EU member states, reducing time-to-market and duplication.

01
βš–οΈ

EMA Oversight Ensures Harmonized Evaluation

EMA oversight ensures harmonized evaluation across all EU member states, providing a consistent and unified scientific assessment of your medicinal product.

Centralized Procedure

02
⚑

Faster Access Across All EU Countries

A single application through the Centralized Procedure delivers marketing authorization simultaneously across all EU member states, significantly reducing time-to-market.

Pan-European Access

03
πŸ“‹

Duplicate Authorizations Possible in Certain Cases

Duplicate authorizations are possible in certain cases, offering additional flexibility for companies with multiple products or product variations within the centralized framework.

Flexibility

Regulatory Maintenance & Risk Management

Compliance Doesn’t End with Marketing Authorization

We provide continuous support to manage updates, respond to inspections, and handle recalls or regulatory changes. Our proactive compliance solutions ensure your products remain legally marketed without interruption.

πŸ”„

Regulatory Maintenance

Ongoing compliance support after marketing authorization is granted

Lifecycle management of authorized medicinal products

Labeling updates and regulatory change management

Response to regulatory authority inspections

Handling of recalls and urgent safety communications

Variation submissions and post-authorization changes

πŸ›‘οΈ

Proactive Risk Management

Proactive compliance solutions to sustain uninterrupted market presence

Proactive compliance monitoring to prevent regulatory gaps

Regulatory intelligence to anticipate upcoming requirements

Pharmacovigilance and safety reporting obligations

Risk minimization strategies and regulatory action plans

Continuous support to ensure products remain legally marketed

Our Expertise

Our Comprehensive Support Approach

Expert-led regulatory support helping pharmaceutical companies seamlessly navigate every step of the European compliance journey.

πŸ—ΊοΈ

Regulatory Roadmaps for Market Access

Strategic regulatory roadmaps tailored to your product profile and target European markets.

πŸ“‘

Regulatory Affairs & Intelligence

Proactive monitoring of European regulatory developments and market access intelligence.

πŸ“

Dossier Management & Publishing

Full dossier management and publishing aligned with EMA and national agency standards.

πŸ“€

End-to-End Submission Handling

Complete management of regulatory submissions across Centralized, Decentralized, MRP, and National Procedures.

πŸ”¬

Pharmacovigilance (PV) Services

Comprehensive pharmacovigilance support including safety reporting and risk minimization obligations.

πŸ§‘β€πŸ’Ό

In-Country Regulatory Representation

Local regulatory representation across European member states for national procedure and compliance requirements.

Get Started

Ready to Navigate the European Regulatory Landscape?

Our expert-led regulatory support helps pharmaceutical companies seamlessly navigate every step of the compliance journey β€” from dossier preparation through post-approval lifecycle management.

Scroll to Top